title: Disseminated histoplasmosis in patients with AIDS.
abstract: Disseminated histoplasmosis was diagnosed in 36 (4%) of 980 patients with AIDS seen at Parkland Memorial Hospital in Dallas, Texas before September 30, 1989. Diagnostic sensitivity of blood culture plus examination of peripheral smear was 88%; sensitivity of bone marrow aspiration and blood culture was 80%. Median CD4 lymphocyte count at diagnosis was 33/cu mm. Median actuarial survival from the date histoplasmosis was diagnosed was 188 days. Thirteen (36%) of the 36 patients died before adequate antifungal therapy could be administered, while 13 survived long enough to receive 1,500 mg of amphotericin B; actuarial survival of the latter group from the date 1,500 mg of amphotericin B had been infused was 47% at 1 year. The substantial early mortality of AIDS-associated disseminated histoplasmosis and the modestly encouraging survival of those who were diagnosed in time to receive adequate therapy raise the issues of surveillance, prophylaxis, and empiric therapy for this infection in selected HIV-positive patients.
authors.affiliation: Department of Medicine, University of Texas Southwestern Medical School, Dallas 75235-8889.
authors.forename: S D
authors.initials: SD
authors.lastname: Nightingale
authors.forename: J M
authors.initials: JM
authors.lastname: Parks
authors.forename: S M
authors.initials: SM
authors.lastname: Pounders
authors.forename: D K
authors.initials: DK
authors.lastname: Burns
authors.forename: J
authors.initials: J
authors.lastname: Reynolds
authors.forename: J A
authors.initials: JA
authors.lastname: Hernandez
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000453:epidemiology / Q000401:mortality / Q000473:pathology; D000206:Actuarial Analysis; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D003453:Cryptococcosis / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000473:pathology; D005069:Evaluation Studies as Topic; D005260:Female; D006658:Histoplasma / Q000302:isolation & purification; D006660:Histoplasmosis / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000473:pathology; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013781:Texas / Q000453:epidemiology; D013997:Time Factors
chemical_list: D000666:Amphotericin B; D007654:Ketoconazole